CHU Hopitaux de Bordeaux - Hôpital Saint-André

Bordeaux 33000

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, Head and Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Pyruvate Kinase Deficiency

Studies at this site

• Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination — Running, not enrolling
• Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007 — Completed